These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22734836)

  • 21. Re: Does previous extracorporeal shock wave lithotripsy affect the performance and outcome of percutaneous nephrolithotomy? E. Yuruk, A. Tefekli, E. Sari, M. A. Karadag, A. Tepeler, M. Binbay and A. Y. Muslumanoglu J Urol 2009; 181: 663-667.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Nov; 182(5):2534-5. PubMed ID: 19766255
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Contemporary Trends in Percutaneous Nephrolithotomy in the United States: 1998-2011.
    Assimos DG
    J Urol; 2016 Sep; 196(3):776. PubMed ID: 27597077
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Mini vs Standard Percutaneous Nephrolithotomy for Renal Stones: A Comparative Study.
    Assimos DG
    J Urol; 2018 Oct; 200(4):693. PubMed ID: 30227575
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: percutaneous nephrolithotomy-position, position, position!
    Falahatkar S; Teimoori M
    Urolithiasis; 2018 Oct; 46(5):501. PubMed ID: 29450577
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Percutaneous Nephrolithotomy in the 80 Years of age and Older Population.
    Griebling TL
    J Urol; 2020 Jul; 204(1):163. PubMed ID: 32293957
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Pre- and Postoperative Predictors of Infection-Related Complications in Patients Undergoing Percutaneous Nephrolithotomy.
    Schaeffer EM
    J Urol; 2018 Jun; 199(6):1376-1377. PubMed ID: 29783554
    [No Abstract]   [Full Text] [Related]  

  • 27. RE: "Predictors for uroseptic shock in patients who undergo minimally invasive percutaneous nephrolithotomy".
    Bozkurt IH; Sefik E; Basmaci I; Yarimoglu S
    Urolithiasis; 2018 Nov; 46(6):595-596. PubMed ID: 29445827
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Predictive Value of Leukocytosis for Infectious Complications after Percutaneous Nephrolithotomy.
    Assimos DG
    J Urol; 2016 Apr; 195(4 Pt 1):1007. PubMed ID: 27302792
    [No Abstract]   [Full Text] [Related]  

  • 29. Miniaturized Percutaneous Nephrolithotomy: A Decade of Paradigm Shift in Percutaneous Renal Access.
    Desai MR; Ganpule AP
    Eur Urol; 2017 Aug; 72(2):236-237. PubMed ID: 28262411
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Staghorn morphometry: a new tool for clinical classification and prediction model for percutaneous nephrolithotomy monotherapy. (From: Mishra S, Sabnis RB, Desai M. J Endourol 2012;26:6-14).
    Mandal S; Goel A; Goyal NK
    J Endourol; 2012 Aug; 26(8):1099. PubMed ID: 22509933
    [No Abstract]   [Full Text] [Related]  

  • 31.
    Juliebø-Jones P; Somani BK
    J Endourol; 2022 Jan; 36(1):47-48. PubMed ID: 34714137
    [No Abstract]   [Full Text] [Related]  

  • 32. Original manuscript by Yu et al.: Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta‑analysis of comparative studies.
    Deng T; Zeng G
    World J Urol; 2020 Oct; 38(10):2663. PubMed ID: 31659463
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: An Easy Risk Stratification to Recommend the Optimal Patients with 2-3 cm Kidney Stones to Receive Retrograde Intrarenal Surgery or Mini-Percutaneous Nephrolithotomy.
    Assimos DG
    J Urol; 2020 Jan; 203(1):26-27. PubMed ID: 31618149
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Aminsharifi A
    J Endourol; 2020 Jun; 34(6):700-701. PubMed ID: 32568591
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Laparoscopic anatrophic nephrolithotomy for management of complete staghorn renal stone: clinical efficacy and intermediate-term functional outcome (from: Alireza Aminsharifi, Patris Hadian, and Kamran Bovei J Endourol 2013;27:000-000).
    Mandal S; Goel A; Yadav R
    J Endourol; 2013 Sep; 27(9):1174. PubMed ID: 23230859
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting sepsis after percutaneous nephrolithotomy.
    Bultitude M; Thomas K
    BJU Int; 2019 Jun; 123(6):914-915. PubMed ID: 31116508
    [No Abstract]   [Full Text] [Related]  

  • 37.
    El-Nahas AR
    J Endourol; 2020 Jun; 34(6):699-700. PubMed ID: 32204611
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Comparison of CROES, S.T.O.N.E, and Guy's Scoring Systems for the Prediction of Stone-Free Status and Complication Rates following Percutaneous Nephrolithotomy in Patients with Chronic Kidney Disease.
    Assimos DG
    J Urol; 2017 Dec; 198(6):1204. PubMed ID: 29144937
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal access during percutaneous nephrolithotomy: increasing value of ultrasonographic guidance for a safer and successful procedure.
    Sarica K
    BJU Int; 2017 Apr; 119(4):509-510. PubMed ID: 28319349
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinically insignificant residual fragments after percutaneous nephrolithotomy: medium-term follow-up.
    Altunrende F; Tefekli A; Stein RJ; Autorino R; Yuruk E; Laydner H; Binbay M; Muslumanoglu AY
    J Endourol; 2011 Jun; 25(6):941-5. PubMed ID: 21599528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.